NCT04049032

Perinatal Opioid Use

MUSC Women's Reproductive Behavioral Health Program for Opioid Use During Pregnancy

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 98 (actual)
• Sponsor: Medical University of South Carolina · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine versus in-person.

Detailed description

Participants: Pregnant women with OUD. Intervention: Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine. Design: A cohort derived from a prospectively collected database including 98 women receiving perinatal OUD treatment in an obstetric practice by telemedicine or in-person and followed until 6-8 weeks postpartum from September, 2017 to December, 2018. Logistic regression with propensity score adjustment was applied to reduce group selection bias and control for potentially confounding variables. Setting: Four outpatient obstetric practices in the southeast.

Conditions

• Opioid Use
• Pregnancy

Interventions

Type	Name	Description
BEHAVIORAL	In-Person Perinatal OUD Treatment	Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine as part of standard of care.
BEHAVIORAL	Perinatal OUD Treatment via Telemedicine	Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine as part of standard of care..

Timeline

• Start date: 2017-09-01
• Primary completion: 2018-12-31
• Completion: 2018-12-31
• First posted: 2019-08-07
• Last updated: 2024-09-19

Locations

1 site across 1 country: United States